SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001213900-19-017467
Filing Date
2019-09-09
Accepted
2019-09-09 08:58:18
Documents
3
Period of Report
2019-09-09
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 CURRENT REPORT f8k090919_delmarpharma.htm 8-K 20816
2 PRESS RELEASE OF DELMAR PHARMACEUTICALS, INC., DATED SEPTEMBER 9, 2019 f8k090919ex99-1_delmarpharma.htm EX-99.1 10374
3 GRAPHIC ex99-1_001.jpg GRAPHIC 15610
  Complete submission text file 0001213900-19-017467.txt   54009
Mailing Address SUITE 720-999 WEST BROADWAY VANCOUVER A1 V5Z 1K5
Business Address SUITE 720-999 WEST BROADWAY VANCOUVER A1 V5Z 1K5 (604) 629-5989
DelMar Pharmaceuticals, Inc. (Filer) CIK: 0001498382 (see all company filings)

IRS No.: 990360497 | State of Incorp.: NV | Fiscal Year End: 0630
Type: 8-K | Act: 34 | File No.: 001-37823 | Film No.: 191081236
SIC: 2834 Pharmaceutical Preparations
Assistant Director 1